4 completed. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 3 | Completed 3 |
Follow SARS-CoV 2: new trials by email Literature Review of SARS-CoV 2 trials Research Report on SARS-CoV 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Immunogenicity of INO-4800 Followed by Electroporation in Healthy Volunteers for COVID19 INO-4800, CELLECTRA® 2000, Saline-sodium citrate (SSC) buffer - Coronavirus Infection, SARS-CoV 2 | Phase 1 / Phase 2 | Completed | International Vaccine Institute | 79 | 2020-07-15 | 2022-07-18 |
| Safety, Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years. Intramuscular Vaccine - SARS-CoV 2 | Phase 1 | Completed | Medicago | 180 | 2020-07-10 | 2022-04-06 |
| Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 XCEL-UMC-BETA, Placebo - COVID-19, SARS-CoV 2 | Phase 1 / Phase 2 | Completed | Banc de Sang i Teixits | 26 | 2020-05-13 | 2023-01-26 |
| Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection Hyperimmune plasma, Standard of care for SARS-CoV-2 infection - SARS-CoV 2 | Phase 1 / Phase 2 | Completed | Andalusian Network for Design and Translation of Advanced Therapies | 72 | 2020-04-23 | 2022-04-06 |
COVID-19 (1) · Coronavirus Infections (1) · Respiratory Distress Syndrome (1)
Coronaviridae Infections (2) · Infections (2) · Nidovirales Infections (2) · RNA Virus Infections (2) · Virus Diseases (2) · Coronavirus Infections (1) · Lung Diseases (1) · Pneumonia (1) · Pneumonia, Viral (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1)
Buffers (1) · COVID-19 Serotherapy (1) · Standard of Care (1) · reluscovtogene ralaplasmid (1)
Andalusian Network for Design and Translation of Advanced Therapies (1) · Banc de Sang i Teixits (1) · International Vaccine Institute (1) · Medicago (1)
Spain (2) · Canada (1) · South Korea (1)
Antoni Torres, MD, PhD (1) · Brian J Ward, MD (1) · Eu Suk Kim, MD (1) · Myoung-don Oh, MD (1)